Key risks
- Revenue contracted 70% from ₹253.9 Cr (Dec 2023) to ₹72.34 Cr (Dec 2024), no recovery signal in latest quarter; verify root cause and whether contraction is cyclical or structural.
- Operating margins deeply negative (OPM -11.36% Sep 2024) and remain negative (OPM -0.59% Mar 2025); identify whether fixed-cost burden or pricing pressure prevents profitability.
- Net losses 4 straight quarters (Jun 2024–Mar 2025); verify burn rate and cash runway if recovery stalls.
- Institutional investor participation near-zero (FII 0.32%, DII 0.11% Jun 2026); verify whether reflects analyst neglect or governance concerns.
Generated analysis · source review pending